Skip to main content
. 2021 Feb 28;13(3):803. doi: 10.3390/nu13030803

Figure 2.

Figure 2

Summary of the molecular mechanisms reported in recent literature potentially mediating the beneficial effects of methylxanthines in respect to Parkinson´s disease.